Nucleoside Analog Antiviral [EPC]: Side Effects & Safety Data for 4 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Nucleoside Analog Antiviral [EPC] includes 4 drugs with a combined 56,473 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
4
Drugs in Class
56,473
Combined Reports
All Nucleoside Analog Antiviral [EPC] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| RIBAVIRIN | Ribavirin | 43,397 | 2,494 | 8,495 | 5.7% |
| VALGANCICLOVIR | VALGANCICLOVIR | 7,913 | 1,274 | 3,092 | 16.1% |
| GANCICLOVIR | Ganciclovir | 4,990 | 1,469 | 1,735 | 29.4% |
| TRIFLURIDINE | Trifluridine | 173 | 26 | 34 | 15.0% |
Common Side Effects in Nucleoside Analog Antiviral [EPC] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Fatigue | 5,693 | 310 |
| Anaemia | 5,540 | 314 |
| Nausea | 4,609 | 286 |
| Drug ineffective | 4,208 | 746 |
| Off label use | 3,898 | 867 |
| Headache | 3,610 | 265 |
| Pyrexia | 2,950 | 353 |
| Rash | 2,853 | 144 |
| Insomnia | 2,700 | 239 |
| Diarrhoea | 2,554 | 382 |